Business is transacted at breakneck speed, amidst an ever dynamic and globally competitive environment. Vast investments in Research & Development and marketing are required not only to maintain market share, but also growth. Analogous to "building an engine while driving down the road," business must constantly adapt to conditions in flux while continuing to meet market expectations.

In this timely program we look forward to discussing the issues presently on the minds of U.S. business leaders, such as:

• What is the lasting impact of the recession
• How do corporations find and develop forward-looking talent?
• What are their objectives and strategies for growth — if not survival — as all businesses attempt to remain relevant in the 21st century
• For "big pharma" specifically, what does the end of the blockbuster drug era portend, and how will changes on the healthcare landscape impact the industry’s, and its consumers, future

Read more about Deirdre Connelly in the philly.com article "More Changes in Store for Glaxo than the Move to the Navy Yard."

This is the third part in our series examining the financial future of the U.S. and other global economies.

Nostalgia for 1990’s prosperity and fear of what lies ahead loom large for most Americans. As the U.S. moves beyond the Great Recession, we will examine what is on the horizon as government attempts to reduce its debt, and businesses and consumers alike are forced to alter their spending and borrowing habits.  What steps are being taken to encourage job creation?  What can be done to positively impact consumer sentiment? And if the system is broken, what can be done to fix it? And what can we learn from our South American neighbors who are enjoying robust economies?

Join us for this continuing series of programs featuring experts from the fields of business and economics who will offer analyses and opinions on economies both in the U.S. and abroad.